Literature DB >> 15866359

Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression.

Ertugrul Esel1, Saliha Ozsoy, Ahmet Tutus, Seher Sofuoglu, Sukru Kartalci, Fahri Bayram, Zaliha Kokbudak, Mustafa Kula.   

Abstract

Leptin is a product of the obese gene and plays an important role in the regulation of body weight and food intake. Weight and appetite are frequently altered in depression. So far, inconsistent results have been reported in terms of leptin levels in depression. Therefore, the authors investigated serum leptin levels in patients with depression and in healthy controls, and whether there was any alteration throughout antidepressant treatment. Female patients showed significantly higher leptin levels than those of the control females both before and after the response to antidepressant treatment, whereas no difference was found between the male patients and the male controls. The improvement from depression with antidepressant treatment caused a further elevation on the leptin levels, in both female and male patients. These findings confirm an increase in leptin levels in depressive patients and presence of a sexual dimorphism. Moreover, clinical response to antidepressant treatment seems to have an additional increasing effect on leptin levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866359     DOI: 10.1016/j.pnpbp.2005.01.009

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  24 in total

1.  Fasting leptin and glucose in normal weight, over weight and obese men and women diabetes patients with and without clinical depression.

Authors:  Darakhshan Jabeen Haleem; Shehnaz Sheikh; Asher Fawad; Muhammad A Haleem
Journal:  Metab Brain Dis       Date:  2017-02-15       Impact factor: 3.584

Review 2.  Mood disorders: A potential link between ghrelin and leptin on human body?

Authors:  Stalo Zarouna; Greta Wozniak; Anastasia Ioannis Papachristou
Journal:  World J Exp Med       Date:  2015-05-20

3.  Leptin: a potential novel antidepressant.

Authors:  Xin-Yun Lu; Chung Sub Kim; Alan Frazer; Wei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-19       Impact factor: 11.205

4.  The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model.

Authors:  Hatem M Abuohashish; Mohammed M Ahmed; Salim S Al-Rejaie; Kamal E H Eltahir
Journal:  Acta Pharmacol Sin       Date:  2014-12-29       Impact factor: 6.150

Review 5.  Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders.

Authors:  Milind V Masule; Sumit Rathod; Yogeeta Agrawal; Chandragouda R Patil; Kartik T Nakhate; Shreesh Ojha; Sameer N Goyal; Umesh B Mahajan
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-06-13

6.  Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features.

Authors:  Zeynep Kotan; Emre Sarandöl; Emine Kırhan; Güven Ozkaya; Selcçuk Kırlı
Journal:  Ther Adv Psychopharmacol       Date:  2012-04

Review 7.  Depression as a risk factor for osteoporosis.

Authors:  Giovanni Cizza; Svetlana Primma; Gyorgy Csako
Journal:  Trends Endocrinol Metab       Date:  2009-09-09       Impact factor: 12.015

8.  The role of adipokines in the rapid antidepressant effects of ketamine.

Authors:  R Machado-Vieira; P W Gold; D A Luckenbaugh; E D Ballard; E M Richards; I D Henter; R T De Sousa; M J Niciu; P Yuan; C A Zarate
Journal:  Mol Psychiatry       Date:  2016-04-05       Impact factor: 15.992

Review 9.  Suggested Biomarkers for Major Depressive Disorder.

Authors:  Yunus Hacimusalar; Ertuğrul Eşel
Journal:  Noro Psikiyatr Ars       Date:  2018-05-28       Impact factor: 1.339

10.  Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels.

Authors:  Stefan Kloiber; Stephan Ripke; Martin A Kohli; Simone Reppermund; Daria Salyakina; Rudolf Uher; Peter McGuffin; Roy H Perlis; Steven P Hamilton; Benno Pütz; Johannes Hennings; Tanja Brückl; Torsten Klengel; Thomas Bettecken; Marcus Ising; Manfred Uhr; Tatjana Dose; Paul G Unschuld; Josef Zihl; Elisabeth Binder; Bertram Müller-Myhsok; Florian Holsboer; Susanne Lucae
Journal:  Eur Neuropsychopharmacol       Date:  2012-09-29       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.